Browse: Departments Dates Agencies
SUBJECT CATEGORY: Notice of Establishment
DOCUMENT SUMMARY:
Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Emerging Neuroscience and Training Integrated Review Group.
The Emerging Neuroscience and Training Integrated Review Group shall
[[Page 65051]]
provide advice and recommendations to the Director, NIH, and the
Director, Center for Scientific Review (CSR), on the scientific and
technical merit of applications for grantsinaid for research,
research training or researchrelated grants and cooperative
agreements, or contact proposals relating to (1) the crosscutting
technologies that serve all of the neurosciences, including
neuroinformatics and imaging and molecular neurogenetics; (2)
crosscutting emerging science in the small business area for all of the
neurosciences; and (3) the training areas for all of the neurosciences.
Duration of this committee is continuing unless formally determined
by the Director, NIH, that termination would be in the best public interest.
Dated: November 1, 2007.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 075744 Filed 111607; 8:45 am]
BILLING CODE 414001M
SUMMARY: Emerging Neuroscience and Training Integrated Review Group,
DOCUMENT BODY 2:
Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Emerging Neuroscience and Training Integrated Review Group.
The Emerging Neuroscience and Training Integrated Review Group shall
[[Page 65051]]
provide advice and recommendations to the Director, NIH, and the
Director, Center for Scientific Review (CSR), on the scientific and
technical merit of applications for grantsinaid for research,
research training or researchrelated grants and cooperative
agreements, or contact proposals relating to (1) the crosscutting
technologies that serve all of the neurosciences, including
neuroinformatics and imaging and molecular neurogenetics; (2)
crosscutting emerging science in the small business area for all of the
neurosciences; and (3) the training areas for all of the neurosciences.
Duration of this committee is continuing unless formally determined
by the Director, NIH, that termination would be in the best public interest.
Dated: November 1, 2007.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 075744 Filed 111607; 8:45 am]
BILLING CODE 414001M
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 40 CFR Part 63 33 CFR Part 100 50 CFR Part 622 50 CFR Part 660 26 CFR Part 301 44 CFR Part 65 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 10 CFR Part 50 44 CFR Part 64 49 CFR Part 571 39 CFR Part 3020